Tagged with “molecular markers”

ASCO Research Highlights: Molecular Markers in Stage II and III Colon Cancer

Several studies presented at ASCO looked a biomarkers that might predict cancer recurrence or patient survival in stage II and III colon cancer and whether patients could be chosen to receive chemotherapy based on those markers. Of special interest was the hypothesis offered by two researchers from the PETACC-3 clinical trial that stage II and stage III may be very different biologically. As Dr. Arnaud Roth said, “. . .in other words, could be different diseases.” Continue reading…

Posted by Kate Murphy on June 12th, 2009
Posted in: Research & Treatment News | 1 Comment »
Tags: ASCO 2009, molecular markers, stage II colon cancer, stage III colon cancer

Search C3

Free Patient Webinar

Stage II Colon Cancer: Chemo or Not? Find Your Solution
Monday, September 20, 2010
8:00 PM - 9:00 PM EDT

Stage II colon cancer patients face tough decisions about whether the possible benefits of chemotherapy outweigh its risks and challenges. This webinar will explore the answers with you.

Follow C3

Join us on Facebook

Watch us on YouTube

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.